Toggle Nav
Close
  • Menu
  • Setting

Anti-IL-6Ra/CD126 Antibody (Sapelizumab)

Catalog No.
F1292
Anti-IL-6Ra/CD126 Antibody (Sapelizumab)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Satralizumab is a humanized monoclonal antibody that is a potent inhibitor of interleukin-6 (IL-6). Satralizumab prevents the formation and development of dTAA in Rattus norvegicus. Satralizumab is used in the study of neuromyelitis optica (NMOSD) and descending thoracic aortic aneurysm (dTAA).

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145 kDa

Shipping

Dry ice

Cas No.

1535963-91-7

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Chugai 2nd Gen anti-IL-6R

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P08887

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG2SA

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

IL-6Ra / CD126

Note

Please avoid freeze-thaw cycles.